Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

Core Viewpoint - Novo Nordisk and Eli Lilly have denied any partnership with telehealth website Mangoceuticals Inc regarding weight-loss drugs, contradicting a press release from Mangoceuticals [1] Company Summary - Novo Nordisk and Eli Lilly both issued statements clarifying that they do not collaborate with Mangoceuticals Inc on weight-loss medications [1]